David Frigeri’s Post

GenAI can usher in a new era of scientific discovery to enrich patient experience, but there are concerns to navigate in order to reach this potential. In the final article of this series, Slalomer Collin Burdick poses solutions to these challenges. #SlalomDailyDose #SlalomLifeSciences #ImWithSlalom

GenAI can usher in a new era of scientific discovery to enrich patient experience, but there are concerns to navigate in order to reach this potential. In the final article of this series, Slalomer Collin Burdick poses solutions to these challenges. #SlalomDailyDose #SlalomLifeSciences #ImWithSlalom

GenAI can usher in a new era of scientific discovery to enrich patient experience, but there are concerns to navigate in order to reach this potential. In the final article of this series, Slalomer Collin Burdick poses solutions to these challenges. #SlalomDailyDose #SlalomLifeSciences #ImWithSlalom

GenAI can usher in a new era of scientific discovery to enrich patient experience, but there are concerns to navigate in order to reach this potential. In the final article of this series, Slalomer Collin Burdick poses solutions to these challenges. #SlalomDailyDose #SlalomLifeSciences #ImWithSlalom

GenAI can usher in a new era of scientific discovery to enrich patient experience, but there are concerns to navigate in order to reach this potential. In the final article of this series, Slalomer Collin Burdick poses solutions to these challenges. #SlalomDailyDose #SlalomLifeSciences #ImWithSlalom

GenAI can usher in a new era of scientific discovery to enrich patient experience, but there are concerns to navigate in order to reach this potential. In the final article of this series, Slalomer Collin Burdick poses solutions to these challenges. #SlalomDailyDose #SlalomLifeSciences #ImWithSlalom

GenAI can usher in a new era of scientific discovery to enrich patient experience, but there are concerns to navigate in order to reach this potential. In the final article of this series, Slalomer Collin Burdick poses solutions to these challenges. #SlalomDailyDose #SlalomLifeSciences #ImWithSlalom

GenAI can usher in a new era of scientific discovery to enrich patient experience, but there are concerns to navigate in order to reach this potential. In the final article of this series, Slalomer Collin Burdick poses solutions to these challenges. #SlalomDailyDose #SlalomLifeSciences #ImWithSlalom

GenAI can usher in a new era of scientific discovery to enrich patient experience, but there are concerns to navigate in order to reach this potential. In the final article of this series, Slalomer Collin Burdick poses solutions to these challenges. #SlalomDailyDose #SlalomLifeSciences #ImWithSlalom